Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 207

1.

Editor's Letter.

Miles JR.

J Correct Health Care. 2017 Apr;23(2):146. doi: 10.1177/1078345817701044. No abstract available.

PMID:
28421892
2.

How the Cobra Got Its Flesh-Eating Venom: Cytotoxicity as a Defensive Innovation and Its Co-Evolution with Hooding, Aposematic Marking, and Spitting.

Panagides N, Jackson TN, Ikonomopoulou MP, Arbuckle K, Pretzler R, Yang DC, Ali SA, Koludarov I, Dobson J, Sanker B, Asselin A, Santana RC, Hendrikx I, van der Ploeg H, Tai-A-Pin J, van den Bergh R, Kerkkamp HM, Vonk FJ, Naude A, Strydom MA, Jacobsz L, Dunstan N, Jaeger M, Hodgson WC, Miles J, Fry BG.

Toxins (Basel). 2017 Mar 13;9(3). pii: E103. doi: 10.3390/toxins9030103.

3.

Letter to the Editor.

Anabtawi A, Miles JM.

Endocr Pract. 2017 Mar;23(3):380-381. doi: 10.4158/1934-2403-23.3.380. No abstract available.

PMID:
28288303
4.

Non-destructive Phenotyping to Identify Brachiaria Hybrids Tolerant to Waterlogging Stress under Field Conditions.

Jiménez JC, Cardoso JA, Leiva LF, Gil J, Forero MG, Worthington ML, Miles JW, Rao IM.

Front Plant Sci. 2017 Feb 13;8:167. doi: 10.3389/fpls.2017.00167. eCollection 2017.

5.

The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis.

Cero C, Razzoli M, Han R, Sahu BS, Patricelli J, Guo Z, Zaidman NA, Miles JM, O'Grady SM, Bartolomucci A.

Mol Metab. 2016 Oct 31;6(1):148-158. doi: 10.1016/j.molmet.2016.10.005. eCollection 2017 Jan.

6.

Editor's Letter.

Miles JR.

J Correct Health Care. 2017 Jan;23(1):10. doi: 10.1177/1078345816686729. No abstract available.

PMID:
28100147
7.

LETTER TO THE EDITOR.

Anabtawi A, Miles JM.

Endocr Pract. 2016 Dec 14. [Epub ahead of print] No abstract available.

PMID:
27967231
8.

Mining, visualizing and comparing multidimensional biomolecular data using the Genomics Data Miner (GMine) Web-Server.

Proietti C, Zakrzewski M, Watkins TS, Berger B, Hasan S, Ratnatunga CN, Brion MJ, Crompton PD, Miles JJ, Doolan DL, Krause L.

Sci Rep. 2016 Dec 6;6:38178. doi: 10.1038/srep38178.

9.

Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase.

Cole DK, van den Berg HA, Lloyd A, Crowther MD, Beck K, Ekeruche-Makinde J, Miles JJ, Bulek AM, Dolton G, Schauenburg AJ, Wall A, Fuller A, Clement M, Laugel B, Rizkallah PJ, Wooldridge L, Sewell AK.

J Biol Chem. 2017 Jan 20;292(3):802-813. doi: 10.1074/jbc.M116.741603. Epub 2016 Nov 30.

10.

Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy.

Blake SJ, Dougall WC, Miles JJ, Teng MW, Smyth MJ.

Clin Cancer Res. 2016 Nov 1;22(21):5183-5188. Epub 2016 Sep 12.

PMID:
27620276
11.

Editor's Letter.

Miles JR.

J Correct Health Care. 2016 Oct;22(4):279. No abstract available.

PMID:
27742852
12.

Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients.

Dasari V, Schuessler A, Smith C, Wong Y, Miles JJ, Smyth MJ, Ambalathingal G, Francis R, Campbell S, Chambers D, Khanna R.

Mol Ther Methods Clin Dev. 2016 Aug 24;3:16058. doi: 10.1038/mtm.2016.58. eCollection 2016.

13.

Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans.

Varghese RT, Dalla Man C, Sharma A, Viegas I, Barosa C, Marques C, Shah M, Miles JM, Rizza RA, Jones JG, Cobelli C, Vella A.

J Clin Endocrinol Metab. 2016 Dec;101(12):4816-4824. Epub 2016 Sep 7.

PMID:
27603902
14.

METFORMIN: NONGLYCEMIC EFFECTS AND POTENTIAL NOVEL INDICATIONS.

Anabtawi A, Miles JM.

Endocr Pract. 2016 Aug;22(8):999-1007. doi: 10.4158/EP151145.RA.

PMID:
27579542
15.

Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.

Karunarathne DS, Horne-Debets JM, Huang JX, Faleiro R, Leow CY, Amante F, Watkins TS, Miles JJ, Dwyer PJ, Stacey KJ, Yarski M, Poh CM, Lee JS, Cooper MA, Rénia L, Richard D, McCarthy JS, Sharpe AH, Wykes MN.

Immunity. 2016 Aug 16;45(2):333-45. doi: 10.1016/j.immuni.2016.07.017.

PMID:
27533014
16.

Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.

Cole DK, Bulek AM, Dolton G, Schauenberg AJ, Szomolay B, Rittase W, Trimby A, Jothikumar P, Fuller A, Skowera A, Rossjohn J, Zhu C, Miles JJ, Peakman M, Wooldridge L, Rizkallah PJ, Sewell AK.

J Clin Invest. 2016 Sep 1;126(9):3626. doi: 10.1172/JCI89919. Epub 2016 Aug 15. No abstract available.

17.

Maintenance of the EBV-specific CD8+ TCRαβ repertoire in immunosuppressed lung transplant recipients.

Nguyen TH, Bird NL, Grant EJ, Miles JJ, Thomas PG, Kotsimbos TC, Mifsud NA, Kedzierska K.

Immunol Cell Biol. 2017 Jan;95(1):77-86. doi: 10.1038/icb.2016.71. Epub 2016 Oct 4.

18.

Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells.

Laugel B, Lloyd A, Meermeier EW, Crowther MD, Connor TR, Dolton G, Miles JJ, Burrows SR, Gold MC, Lewinsohn DM, Sewell AK.

J Immunol. 2016 Aug 1;197(3):971-82. doi: 10.4049/jimmunol.1501402. Epub 2016 Jun 15.

19.

Editor's Letter.

Miles JR.

J Correct Health Care. 2016 Jul;22(3):178-9. doi: 10.1177/1078345816654232. No abstract available.

PMID:
27302702
20.

Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.

Smith C, Brennan RM, Tey SK, Smyth MJ, Burrows SR, Miles JJ, Hill GR, Khanna R.

J Virol. 2016 Jul 27;90(16):7497-507. doi: 10.1128/JVI.00297-16. Print 2016 Aug 15.

Supplemental Content

Loading ...
Support Center